Analyst Reco. Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
17.57 ^USD	-1.13%		+2.09%	-22.39%

Feb. 27	Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	MT
Feb. 23	UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating	Feb. 27	MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating	Feb. 23	MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating	Feb. 22	MT
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating	Dec. 06	MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target	Nov. 30	MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating	Nov. 29	MT
Jefferies Downgrades Cross Country Healthcare to Hold From Buy, Adjusts Price Target to $21 From $32	Nov. 03	MT
Barrington Cuts Price Target on Cross Country Healthcare to $29 From $35 Amid Reduction in Estimates, Keeps at Outperform	23-08-14	MT
Credit Suisse Adjusts Cross Country Healthcare's Price Target to $26 From $27, Keeps Neutral Rating	23-08-08	MT
William Blair Initiates Cross Country Healthcare at Outperform Rating	23-06-26	MT
Barrington Research Cuts Cross Country Healthcare's Price Target to $35 From $42, Maintains Outperform Rating	23-05-31	MT
Credit Suisse Lowers Cross Country Healthcare's Price Target to $27 From $32, Keeps Neutral Rating	23-05-05	MT
Truist Securities Adjusts Cross Country Healthcare Price Target to $25 From $38, Maintains Hold Rating	23-05-02	MT
Loop Capital Initiates Cross Country Healthcare at Buy Rating With $30 Price Target	23-03-10	MT
Barrington Trims Price Target on Cross Country Healthcare to $42 From $45, Reiterates Outperform Rating	23-03-01	MT
Benchmark Capital Adjusts Cross Country Healthcare Price Target to $40 From $45, Maintains Buy Rating	23-02-23	MT
Credit Suisse Lifts Cross Country Healthcare's Price Target to $32 From $31 After Higher-Than-Expected Q4 Results, Keeps Neutral Rating	23-02-23	MT
Barrington Raises Price Target on Cross Country Healthcare to $45 From $41, Affirms Outperform Rating	22-11-07	MT
Truist Securities Downgrades Cross Country Healthcare to Hold From Buy; Price Target is $36	22-10-05	MT
Barrington Research Raises Price Target for Cross Country Healthcare to $41 From $40, Maintains Outperform Rating	22-09-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cross Country Healthcare, Inc.

Equities

CCRN

US2274831047

Analyst Reco.

Filters